Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Cynthia Besch-Williford"'
Publikováno v:
Breast Cancer Research and Treatment. 192:53-63
Most hormone-dependent human breast cancers develop resistance to anti-hormone therapy over time. Our goal was to identify novel treatment strategies to avoid this drug resistance and thereby control hormone-dependent breast cancer.Sulforhodamine B a
Autor:
Patri Vergara, Gregory Ballard, Cynthia Besch-Williford, Nobuhito Hayashimoto, Cynthia Pekow, Ana Perez, Katja Schmidt, William Shek, Martin Toft, Atsushi Yoshiki
Publikováno v:
ILAR journal.
ICLAS Laboratory Animal Quality Network (LAQN) programs currently consist of the Performance Evaluation Program (PEP), which focuses on microbial monitoring by and for laboratory animal diagnostic laboratories, and the Genetic Reference Monitoring Pr
Autor:
Anthony M Belenchia, Matthew T Cook, Cynthia Besch-Williford, Yayun Liang, Salman M. Hyder, Rolf A. Brekken
Publikováno v:
Breast Cancer : Targets and Therapy
Yayun Liang,1 Cynthia Besch-Williford,2 Matthew T Cook,3 Anthony Belenchia,4 Rolf A Brekken,5 Salman M Hyder11Department of Biomedical Sciences and Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO, USA; 2IDEXX BioAnalytics,
Autor:
Kevin L. Fritsche, Cynthia Besch-Williford, George E. Rottinghaus, Y. C. Li, Nicholas J.E. Starkey, Monica Peña-Luna, Dennis B. Lubahn, Nathaniel W. Mahloch
3,3′-Diindolylmethane (DIM) is an acid-derived dimer of indole-3-carbinol, found in many cruciferous vegetables, such as broccoli, and has been shown to inhibit prostate cancer (PCa) in several in vitro and in vivo models. We demonstrated that DIM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b680018752928de05bebd40e1792e85c
Publikováno v:
Journal of the Endocrine Society
Mutations in the tumor suppressor p53 gene are frequently associated with various cancers, including human breast cancer. Unlike wild-type p53 (wtp53), mutant p53 protein (mtp53) fails to promote apoptosis, resulting in tumor cell survival and resist
Publikováno v:
Cancer Research. 76:P1-16
Clinical trials and epidemiological evidence show that combined estrogen (E) and progestin (P) hormone replacement therapy (HRT) increases the risk of breast cancer in postmenopausal women, whereas HRT containing E alone does not. Tumor progression i
Publikováno v:
Breast Cancer : Targets and Therapy
Yayun Liang,1 Benford Mafuvadze,1 Cynthia Besch-Williford,2 Salman M Hyder1 1Deparment of Biomedical Sciences and Dalton Cardiovascular Research Center, Columbia, MO, USA; 2IDEXX BioResearch, Columbia, MO, USA Background: Between 30 and 40% of human
Autor:
Sandy Goyette, Mark R. Ellersieck, Matthew Cook, Salman M. Hyder, Cynthia Besch-Williford, Benford Mafuvadze
Publikováno v:
Oncology Reports. 35:825-832
Postmenopausal women undergoing hormone-replacement therapy containing both progestins and estrogens are at an increased risk of developing breast cancer compared with women taking estrogen alone. We recently demonstrated that medroxyprogesterone ace
Autor:
Glenn A. Jackson, Hui Lin, Korey J. Brownstein, Sara K. Drenkhahn, Nicholas J.E. Starkey, Yong Zhang, Kevin L. Fritsche, William R. Lamberson, Yuan Lu, Valeri V. Mossine, William R. Folk, Cynthia Besch-Williford, Dennis B. Lubahn
Publikováno v:
Cell Biology International. 40:131-142
Sutherlandia frutescens is a medicinal plant, traditionally used to treat various types of human diseases, including cancer. Previous studies of several botanicals link suppression of prostate cancer growth with inhibition of the Gli/hedgehog (Gli/Hh
Publikováno v:
Breast Cancer : Targets and Therapy
Matthew T Cook,1,2 Yayun Liang,1,2 Cynthia Besch-Williford,3 Salman M Hyder1,2 1Department of Biomedical Sciences, 2Dalton Cardiovascular Research Center, University of Missouri, 3IDEXX BioResearch, Columbia, MO, USA Abstract: Most breast cancer-rela